Evidence map›Paper›PMID 25193495›Full record

ArticleG3 (Bethesda, Md.)2014

Reference genes for expression studies in hypoxia and hyperglycemia models in human umbilical vein endothelial cells.

Sherin Bakhashab, Sahira Lary, Farid Ahmed, Hans-Juergen Schulten, Ayat Bashir, Fahad W Ahmed, Abdulrahman L Al-Malki, Hasan S Jamal, Mamdooh A Gari, Jolanta U Weaver

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. 3D In Vitro Blood-Brain-Barrier Model for Investigating Barrier Insults.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
  9. A pleiotropic hypoxia-sensitiveScience advances · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of rosuvastatin on the expression of candidate geneExperimental and therapeutic medicine · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sherin BakhashabInstitute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, United Kingdom Biochemistry Department, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia Center of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.ORCID http://orcid.org/0000-0003-1580-0409
Sahira LaryBiochemistry Department, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
Farid AhmedCenter of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
Hans-Juergen SchultenCenter of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
Ayat BashirInstitute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, United Kingdom.
Fahad W AhmedInstitute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, United Kingdom.
Abdulrahman L Al-MalkiBiochemistry Department, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
Hasan S JamalDepartment of Obstetrics and Gynaecology, Faculty of Medicine, King Abdulaziz University, P.O. Box 80215, Jeddah 21589, Saudi Arabia.
Mamdooh A GariCenter of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
Jolanta U WeaverInstitute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, United Kingdom Jolanta.Weaver@newcastle.ac.uk.
King Abdulaziz University · SANewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human umbilical vein endothelial cell (HUVEC)-based gene expression studies performed under hypoxia and/or hyperglycemia show huge potential for modeling endothelial cell response in cardiovascular disease and diabetes. However, such studies require reference genes that are stable across the whole range of experimental conditions. These reference genes have not been comprehensively defined to date. We applied human genome-wide microarrays and quantitative real-time PCR (qRT-PCR) on RNA obtained from primary HUVEC cultures that were incubated for 24 hr either in euglycemic or in hyperglycemic conditions and then subjected to short-term CoCl2-induced hypoxia for 1, 3, or 12 hr. Using whole-transcript arrays, we selected 10 commonly used reference genes with no significant expression variation across eight different conditions. These genes were ranked using NormFinder software according to their stability values. Consequently, five genes were selected for validation by qRT-PCR. These were ribosomal protein large P0 (RPLP0), transferrin receptor (TFRC), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β-glucuronidase (GUSB), and β-actin (ACTB). All five genes displayed stable expression under hyperglycemia. However, only RPLP0 and TFRC genes were stable under hypoxia up to 12 hr. Under hyperglycemia combined with hypoxia up to 12 hr, the expression of RPLP0, TFRC, GUSB, and ACTB genes remained unchanged. Our findings strongly confirm that RPLP0 and TFRC are the most suitable reference genes for HUVEC gene expression experiments subjected to hypoxia and/or hyperglycemia for the given experimental conditions. We provide further evidence that even commonly known references genes require experimental validation for all conditions involved.

Indexed as

ActinsAntigens, CDGene Expression ProfilingGlucuronidaseGlycerolphosphate DehydrogenaseHumansHuman Umbilical Vein Endothelial CellsHyperglycemiaHypoxiaReceptors, TransferrinRibosomal ProteinsTranscriptomeActinsAntigens, CDCD71 antigenGlucuronidaseGlycerolphosphate DehydrogenaseReceptors, Transferrinribosomal protein P0Ribosomal ProteinsHUVEChyperglycemiahypoxiareference genes

Identifiers

PMID25193495
PMCPMC4232541
OpenAlexW2124615737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.